The 5th China International Import Expo (CIIE) saw the unveiling of a partnership between GlaxoSmithKline (GSK, NYSE: GSK) and the Chinese Association of STD and AIDS Prevention and Control (CASPC). The collaboration is part of an HIV Sustained Care Advocacy project initiated by the UK major and its joint venture ViiV Healthcare. The partnership aims to enhance the high-quality prevention and control of AIDS in China.
Partnership Objectives
GSK and CASPC will leverage their respective expertise to carry out a range of initiatives, including doctor discussions and exchanges, patient education, public science advocacy, and other projects. These efforts are designed to improve the overall management and prevention of HIV/AIDS in China, ensuring that patients receive sustained and high-quality care.
Background on HIV Sustained Care Advocacy
The HIV Sustained Care Advocacy project is a comprehensive initiative aimed at addressing the ongoing challenges of HIV/AIDS management. By partnering with CASPC, GSK aims to strengthen its commitment to improving public health and supporting the Chinese government’s efforts to control and prevent the spread of HIV/AIDS.-Fineline Info & Tech
